Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA, has demonstrated cardiovascular safety in large clinical trials without evidence of pathological cardiac atrophy
Tirzepatide ODT contains the same active ingredient as injectable tirzepatide and is expected to share the same contraindication profile, though this formulation has not undergone clinical trials
Below: the community-reported dosing landscape (inherited from BPC-157), the reconstitution math, and an honest read on how thin the PDA-specific evidence actually is
The simple meat side drew similar skepticism online to the reaction to Shake Shacks announcement, with some reviewers marveling at the brands decision to market a warm cup of chicken as a "snack," calling the concept "a little unhinged." Others joked that it resembled "a dog menu item," while some praised it as affordable and tasty without feeling too much like health food
This is because the body absorbs all the nutrients from IV therapy, but only a percentage of vitamins from oral supplements
PhageBank also has emergency use Expanded Access IND status for treatment of secondary bacteremia in COVID-19 patients
